Bristol-Myers Squibb (BMY) Tops Q4 EPS by 6c; Issues Light FY15 Outlook
Get Alerts BMY Hot Sheet
Price: $54.23 +1.84%
Revenue Growth %: +1.4%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: +1.4%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.02 billion.
Bristol-Myers Squibb sees FY2015 EPS of $1.55-$1.70, versus the consensus of $1.71.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
- Bristol-Myers Squibb (BMY) Provides Update on the First Phase 3 YELLOWSTONE Trial of Oral Zeposia
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!